Clinical Trials Directory

Trials / Unknown

UnknownNCT01278901

The Effect of PPI Therapy on the Result of Helicobacter Pylori Diagnostic Tests

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

STUDY PROTOCOL: The study will include 30 patients ages 18-80y that had a gastroscopy for various reasons. The patients should not be on PPI therapy . If during the gastroscopy there are some pathologies that require a second look endoscopy after some weeks of therapy (ulcers or esophagitis), the investigators will repeat the gastroscopy within a month. During the first gastroscopy a biopsy will be taken for histological examination and for a rapid urease test and an urea breath test will be done soon after the procedure. If one of the tests is positive the investigators postulate that the Helicobacter pylori is actually present. After the gastroscopy the patient is given a full dose of PPI (as indicated) and helicobacter tests are repeated in the next endoscopy (under PPI therapy) . Any positive test that become negative in the second endoscopy is considered false negative.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2012-02-01
First posted
2011-01-19
Last updated
2011-01-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01278901. Inclusion in this directory is not an endorsement.